Opening founding pharmacy accounts

Peptide bulk drug substance for 503A compounding.

Amidon Pharma supplies BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon to licensed compounding pharmacies, with lot documentation prepared to the HHS enforcement discretion policy of October 28, 2026.

Certificate of Analysis
SPECIMEN · FORMAT ONLY
AMIDON
Substance
BPC-157 acetate
Lot
AP-B157-0001
Manufacturer
Facility address and FEI
Identity
LC-MS and AAA
Purity
HPLC-UV
Endotoxin
USP <85>
Intended use
Human drug compounding
Released by Quality Unit1 / 1
Substances

Covered substances

We supply only the peptides listed in Appendix A of the policy, in the forms and for the routes described in Appendix B. Material is sold as bulk drug substance for patient-specific compounding.

SubstanceFormRoutes under the policy
BPC-157AcetateSubcutaneousIntramuscularOralTopical
TB-500AcetateSubcutaneousIntramuscular
KPVAcetateOralTopical
MOTS-cAcetateSubcutaneousIntramuscular
SemaxFree baseIntranasal
EpitalonAcetateSubcutaneousIntramuscular

If the policy adds substances after the next Pharmacy Compounding Advisory Committee review, we will add them once documentation for each is complete.

Specification

Release testing on every lot

Each certificate names the original manufacturer's facility address and FDA Establishment Identifier, carries the signature of the quality unit, and states that the material is intended for human drug compounding.

TestMethodApplies to
Identity, primaryLC-MS, molecular massAll substances
Identity, orthogonalAmino acid analysisAll substances
PurityHPLC-UVAll substances
AssayPeptide content, HPLCAll substances
Water contentKarl FischerAll substances
Residual TFAIon chromatographyAll substances
Residual solventsGC headspace, ICH Q3CAll substances
Elemental impuritiesICP-MS, ICH Q3DAll substances
Bacterial endotoxinsLAL, USP <85>Injectable routes
Microbial limitsUSP <61> / <62>Injectable routes
With each lot

Supplier file

Manufacturer qualification summary, Appendix B identity sheet and label text for your compounded preparations.

On request

Independent retest

Any lot can be retested by a U.S. ISO 17025 laboratory at our cost. Results are sent directly to you.

Ongoing

Adverse event reporting

A reporting channel for serious adverse events and quality issues, with filings to MedWatch and the relevant state board.

Accounts

Opening an account

We sell only to state-licensed pharmacies and licensed prescribers, and we ship only to licensed addresses.

01

License verification

Send your pharmacy or medical license and NPI. We confirm them with the issuing board before anything else.

02

Quality agreement

We sign a supplier quality agreement and send the documents your qualification file requires.

03

Ordering

Orders are placed by purchase order. Every shipment includes the certificate and supplier file for that lot.

Founding accounts

We are working with a small first group of pharmacies.

Founding accounts help set the format of our supplier file and receive first allocation when lots are released. Tell us which substances you plan to compound and your expected monthly volume.